{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:24:19Z","timestamp":1784291059557,"version":"3.55.0"},"reference-count":62,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-064-01\/503-51-11-001"],"award-info":[{"award-number":["503\/1-064-01\/503-51-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Bullous pemphigoid (BP) is the most common autoimmune blistering disease affecting mainly elderly patients. Still, little is known about the pathogenesis of pruritus in BP or the factors that affect the clinical course of the disease. This study aimed to evaluate the factors influencing the clinical course of BP among older patients. Materials and Methods: A retrospective analysis of medical records of 55 patients with BP hospitalized in the dermatology department in 2015\u20132021 was conducted. The study focused on preliminary diagnosis, medical history, clinical examination (characteristics and location of cutaneous changes), laboratory investigation, and direct and indirect immunofluorescence. Results: Analysis of laboratory results in combination with the clinical course of BP showed that red blood cell count, hemoglobin, and hematocrit values were negatively associated with a risk of erosions and erythema, while MCHC values were positively correlated with a risk of associated pruritus. A correlation was found between neurological diseases and an increased risk of erosions. Conclusions: We have shown that age and neurological conditions, including stroke, affect the clinical course of BP. Further studies on a larger group of patients should be conducted to investigate the different factors affecting the clinical aspect of BP and to understand the relationship between them.<\/jats:p>","DOI":"10.3390\/medicina60101701","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T07:58:32Z","timestamp":1729065512000},"page":"1701","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors Influencing the Clinical Course of Bullous Pemphigoid among Geriatric Patients: A Pilot Study"],"prefix":"10.3390","volume":"60","author":[{"given":"Paula","family":"Mazan","sequence":"first","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Lesiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0109-4331","authenticated-orcid":false,"given":"Igor","family":"Bednarski","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Sobolewska-Sztychny","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Noweta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Narbutt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/abd1806-4841.20199007","article-title":"Bullous pemphigoid","volume":"94","author":"Miyamoto","year":"2019","journal-title":"An. Bras. De Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1111\/pde.12779","article-title":"Spectrum of Clinical Responses to therapies in infantile bullous pemphigoid","volume":"33","author":"Taquin","year":"2016","journal-title":"Pediatr. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-4632.2004.02457.x","article-title":"Prodromal bullous pemphigoid","volume":"45","author":"Lamb","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous pemphigoid: A systematic review","volume":"78","author":"Lamberts","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/jamadermatol.2018.4390","article-title":"Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid","volume":"155","author":"Meijer","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/1346-8138.13782","article-title":"Non-bullous lesions as the first manifestation of bullous pemphigoid: A retrospective analysis of 181 cases","volume":"44","author":"Zhang","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.det.2011.03.008","article-title":"Pathogenesis of bullous pemphigoid","volume":"29","author":"Ujiie","year":"2011","journal-title":"Dermatol. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kridin, K., and Ludwig, R.J. (2018). The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Front. Med., 20.","DOI":"10.3389\/fmed.2018.00220"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1684\/ejd.2017.3066","article-title":"The association between bullous pemphigoid and neurological disorders: A systematic review","volume":"27","author":"Zhang","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: A UK case-control study","volume":"149","author":"Chi","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-4632.2006.02861.x","article-title":"Concomitant psoriasis and bullous pemphigoid: Coincidence or pathogenic relationship?","volume":"45","author":"Wilczek","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/bjd.13097","article-title":"A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1","volume":"171","author":"Sekiya","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00403-017-1772-x","article-title":"Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland","volume":"309","author":"Jagielski","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Autoimmune bullous disease Swiss study group. Incidence of bullous pemphigoid and pemphigus in Switzerland: A 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jamadermatol.2019.3308","article-title":"Prevalence of Pemphigoid as a Potentially Unrecognized Cause of Pruritus in Nursing Home Residents","volume":"155","author":"Meijer","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.blre.2013.12.003","article-title":"The sex difference in haemoglobin levels in adults\u2014mechanisms, causes, and consequences","volume":"28","author":"Murphy","year":"2014","journal-title":"Blood Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Ruzicka","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bjh.16430","article-title":"Blood counts in adult and elderly individuals: Defining the norms over eight decades of life","volume":"189","author":"Zierk","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_23","first-page":"adv00320","article-title":"Characteristics of Pruritus in Bullous Pemphigoid and Impact on Quality of Life: A Prospective Cohort Study","volume":"100","author":"Briand","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_24","first-page":"938","article-title":"Clinical characteristics of pruritus in patients with bullous pemphigoid: A preliminary questionnaire-based study","volume":"37","author":"Kowalczyk","year":"2020","journal-title":"Post\u0119py Dermatol. I Alergol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jdermsci.2007.06.003","article-title":"Intraepidermal nerve fibers increase in dry skin of acetone-treated mice","volume":"48","author":"Tominaga","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"ref_26","first-page":"e5256","article-title":"Pruritus Associated with Chronic Kidney Disease: A Comprehensive Literature Review","volume":"11","author":"Swarna","year":"2019","journal-title":"Cureus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/ijd.15589","article-title":"Recent developments in the pathogenesis of pruritus in bullous pemphigoid","volume":"60","author":"Sun","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fang, H., Zhang, Y., Li, N., Wang, G., and Liu, Z. (2018). The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00407"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"936545","DOI":"10.1155\/2014\/936545","article-title":"Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis","volume":"2014","author":"Zebrowska","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaad.2019.07.060","article-title":"Pathophysiologic mechanisms of itch in bullous pemphigoid","volume":"83","author":"Hashimoto","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/ijpm.ijpm_410_21","article-title":"Role of neutrophil-to-lymphocyte, neutrophil-to-eosinophil and platelet-to-lymphocyte ratios in the diagnosis of bullous pemphigoid and Pemphigus disease","volume":"66","author":"Rai","year":"2023","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/ijd.13736","article-title":"Failure of initial disease control in bullous pemphigoid: A retrospective study of hospitalized patients in a single tertiary center","volume":"56","author":"Kremer","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_33","first-page":"81","article-title":"The association between bullous pemphigoid and neurological disorders in a selected Malaysian population","volume":"70","author":"Kwan","year":"2015","journal-title":"Med. J. Malays."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.17219\/acem\/90922","article-title":"The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center","volume":"28","author":"Kowalczyk","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_35","first-page":"685","article-title":"Coagulation Disorders in Bullous Pemphigoid and Its Mechanism","volume":"41","author":"Yan","year":"2019","journal-title":"Acta Acad. Med. Sin."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bech, R., Kibsgaard, L., and Vestergaard, C. (2018). Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00238"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jaad.2018.02.080","article-title":"Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?","volume":"79","author":"Geller","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0190-9622(84)70266-0","article-title":"Increased frequency of diabetes mellitus in patients with bullous pemphigoid: A case-control study","volume":"11","author":"Chuang","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tasanen, K., Varpuluoma, O., and Nishie, W. (2019). Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01238"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2017.05.006","article-title":"Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis","volume":"77","author":"Atzmony","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_41","first-page":"253","article-title":"Association between bullous pemphigoid and malignancy: A meta-analysis. Australas","volume":"59","author":"Lucariello","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","article-title":"A population-based study of the association between bullous pemphigoid and neurologic disorders","volume":"71","author":"Brick","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40520-015-0459-4","article-title":"Bullous pemphigoid and neurodegenerative diseases: A study in a setting of a Central European university dermatology department","volume":"28","author":"Pietkiewicz","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1590\/abd1806-4841.20153334","article-title":"Bullous pemphigoid and neurological disease: Statistics from a dermatology service","volume":"90","author":"Tarazona","year":"2015","journal-title":"An. Bras. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1684\/ejd.2010.0805","article-title":"Bullous pemphigoid and internal diseases: A case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: A population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00281-019-00759-y","article-title":"Resolution in bullous pemphigoid","volume":"41","author":"Sadik","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/jdv.12136","article-title":"Immunopathological characteristics of patients with bullous pemphigoid and neurological disease","volume":"28","author":"Taghipour","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.matbio.2005.11.004","article-title":"Collagen XVII is expressed in human CNS neurons","volume":"25","author":"Alafuzoff","year":"2006","journal-title":"Matrix Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2007.04.073","article-title":"Distribution of collagen XVII in the human brain","volume":"1158","author":"Suuronen","year":"2007","journal-title":"Brain Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased levels of the bullous pemphigoid BP180 autoantibody are associated with more severe dementia in Alzheimer\u2019s disease","volume":"137","author":"Kokkonen","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/exd.12877","article-title":"One gene but different proteins and diseases: The complexity of dystonin and bullous pemphigoid antigen 1","volume":"25","author":"Favre","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_53","first-page":"240570","article-title":"Collagen XVII: A shared antigen in neurodermatological interactions?","volume":"2013","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/1346-8138.16654","article-title":"What\u2019s new in the pathogeneses and triggering factors of bullous pemphigoid","volume":"50","author":"Ujiie","year":"2023","journal-title":"J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: Results of a prospective multicenter study","volume":"131","author":"Calabresi","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"adv00224","DOI":"10.2340\/00015555-3457","article-title":"A Systematic Review of Drug-Induced Pemphigoid","volume":"100","author":"Verheyden","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00384-014-1924-9","article-title":"Bullous pemphigoid occurring under anti-tumor necrosis factoralpha therapy","volume":"29","author":"Ricci","year":"2014","journal-title":"Int. J. Color. Dis."},{"key":"ref_59","first-page":"134","article-title":"Role of physical factors in the pathogenesis of bullous pemphigoid: Case report series and a comprehensive review of the published work","volume":"43","author":"Chiorean","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5114\/ada.2020.97725","article-title":"UVB-induced bullous pemphigoid in a patient with psoriasis","volume":"39","author":"Ceryn","year":"2022","journal-title":"Adv. Dermatol. Allergol.\/Post\u0119py Dermatol. I Alergol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ghanaatpisheh, A., Safari, M., Haghshenas, H., Motamed-Sanaye, A., Atefi, A.H., Kamangarpour, K., Bagherzadeh, M.A., Kamran-Jahromi, A., Darayesh, M., and Kouhro, N. (2024). New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: A systematic review of case report and case series studies. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1293920"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1701\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:14:24Z","timestamp":1760112864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":62,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["medicina60101701"],"URL":"https:\/\/doi.org\/10.3390\/medicina60101701","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}